27股获券商推荐；稳健医疗目标价涨幅达44%｜券商评级观察

Core Insights - On October 9, brokerages set target prices for listed companies a total of 12 times, with notable increases for companies such as Weikang Medical, Sanor Bio, and Tongfu Microelectronics, showing target price increases of 44.29%, 35.27%, and 24.46% respectively, across the personal care, medical device, and semiconductor industries [1] Brokerage Recommendations - A total of 27 listed companies received brokerage recommendations on October 9, with BYD receiving recommendations from 2 brokerages, while Qianhong Pharmaceutical and Mulinsen each received 1 recommendation [1] Rating Adjustments - Northeast Securities upgraded Jiangfeng Electronics' rating from "Hold" to "Buy" on October 9 [1] Initial Coverage - On October 9, brokerages initiated coverage with 5 new ratings, including: - Dongfang Guoxin received a "Buy" rating from Sinolink Securities - Sanyou Medical received a "Recommended" rating from Ping An Securities - Yidian Tianxia received a "Buy" rating from Zhongyou Securities - Jiangfeng Electronics received a "Buy" rating from Northeast Securities - Cambrian received a "Buy" rating from Huaxin Securities [1]